Press Releases Fennec Pharmaceuticals Inc.

Equities

FENC

CA31447P1009

Market Closed - Nasdaq Other stock markets 01:30:00 02/05/2024 am IST			5-day change	1st Jan Change
9.09 ^USD	-0.98%		+0.22%	-18.98%

23/04	Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing	MT
19/04	Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fennec Pharmaceuticals : Corporate Presentation March 2024	31/03	PU
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update	21/03	GL
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024	19/03	GL
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024	19/03	AQ
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand	18/03	GL
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results	29/02	GL
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results	29/02	AQ
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin	01/02	GL
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin	01/02	AQ
Fennec Announces Incremental $5 Million Investment from Petrichor	05/12	GL
Fennec Announces Incremental $5 Million Investment from Petrichor	05/12	AQ
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences	10/11	GL
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences	10/11	AQ
Fennec Pharmaceuticals : Corporate Presentation November 2023	06/11	PU
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update	06/11	GL
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update	06/11	AQ
Substitute Claims Upheld As Prior Art Is Inapplicable To Pharmaceutical Compositions	31/23/31	AQ
Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023	30/23/30	GL
Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023	30/23/30	AQ
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences	07/23/07	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Fennec Pharmaceuticals Inc.

Equities

FENC

CA31447P1009

Press Releases

Filters